These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 14243103)

  • 1. [CATECHOLAMINE EXCRETION AND THE CLINICAL PICTURE IN THE MANAGEMENT OF CARDIAC INFARCTION AND CORONARY INSUFFICIENCY WITH N 3-PHENYLPROPYL -(2) 1, 1-DIPHENYL-PROPYL-(3)-AMINE].
    GAWELLEK F; ECKERT H
    Dtsch Gesundheitsw; 1964 Jul; 19():1339-46. PubMed ID: 14243103
    [No Abstract]   [Full Text] [Related]  

  • 2. [PHENYL-PROPYL-DIPHENYL-PROPYL-AMINE (SEGONTIN) IN TREATMENT OF SYNDROMES DUE TO CORONARY INSUFFICIENCY IN PATIENTS OVER SEVENTY].
    FRANZINI C; TURRI C; MONTEROSSO A
    Minerva Cardioangiol; 1964 Dec; 12():515-27. PubMed ID: 14269033
    [No Abstract]   [Full Text] [Related]  

  • 3. [METABOLIC EFFECTS OF PHENYL-PROPYL-DIPHENYL-PROPYL-AMINE IN HEALTHY PERSONS AND IN PATIENTS WITH ISCHEMIC HEART DISEASES. II. TECHNICAL METHODS OF RESEARCH AND RESULTS].
    ZOLI A; BRAT A; GIARDINA A
    Riv Crit Clin Med; 1963 Aug; 63():149-73. PubMed ID: 14187838
    [No Abstract]   [Full Text] [Related]  

  • 4. [CONSIDERATIONS ON THE THERAPY OF CORONARY INSUFFICIENCY WITH PHENYL-PROPYL-DIPHENYL-PROPYL-AMINE (FPDPA)].
    RIZZI R; BOZZA G; CESARI A; PASSERELLI A; VANGELISTA A
    Gazz Int Med Chir; 1964 Apr; 68():771-94. PubMed ID: 14159018
    [No Abstract]   [Full Text] [Related]  

  • 5. [CLINICO-ELECTROCARDIOGRAPHIC OBSERVATIONS ON THE ACTIVITY OF N-(3)-PHENYLPROPYL-(2)-1,1-DIPHENYL-PROPYL-(3)-AMINE (F.P.D.P.A.) IN CORONARY INSUFFICIENCY].
    MENCI S
    Gazz Int Med Chir; 1964 Jan; 68():98-109. PubMed ID: 14123796
    [No Abstract]   [Full Text] [Related]  

  • 6. [METABOLIC EFFECTS OF PHENYL-PROPYL-DIPHENYL-PROPYL-AMINE IN HEALTHY PERSONS AND IN PATIENTS WITH ISCHEMIC HEART DISEASES. 3. CRITICAL EXAMINATION OF THE RESULTS AND CONCLUSIVE CONSIDERATIONS].
    ZOLI A; BRAT A; GIARDINA A
    Riv Crit Clin Med; 1963 Aug; 63():174-98. PubMed ID: 14192243
    [No Abstract]   [Full Text] [Related]  

  • 7. [STUDIES ON THE MECHANISM OF ACTION OF PHENYLPROPYL-DIPHENYLPROPYLAMINE (SEGONTIN) IN MAN].
    KUSCHKE HJ; ECKMANN F; IDRISS H; BIECK P
    Verh Dtsch Ges Inn Med; 1964; 70():191-5. PubMed ID: 14294216
    [No Abstract]   [Full Text] [Related]  

  • 8. [CLINICAL TRIALS WITH PHENYL-DIPHENYL-PROPYL-AMINE IN CORONARY INSUFFICIENCY].
    TRILLA SANCHEZ E; BELLONCANEIRO JM; TORNER SOLER M
    Rev Esp Cardiol; 1963 Oct; 16():873-84. PubMed ID: 14117507
    [No Abstract]   [Full Text] [Related]  

  • 9. [METABOLIC EFFECTS OF PHENYL-PROPYL-DIPHENYL-PROPYL-AMINE IN THE HEALTHY MAN AND IN THE PATIENT WITH ISCHEMIC HEART DISEASE. I. CLINICAL AND EXPERIMENTAL PHARMACOLOGY OF FEDIPRA].
    ZOLI A; BRAT A; GIARDINA A
    Riv Crit Clin Med; 1963 Apr; 63():75-90. PubMed ID: 14277814
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinical evaluation of the action of 3,3-diphenyl-N-(alpha-methylphenethyl)-propylamine in coronary insufficiency].
    PARON R; DA BROI GL
    Gazz Int Med Chir; 1962 Nov; 66():2496-521. PubMed ID: 13941569
    [No Abstract]   [Full Text] [Related]  

  • 11. [3'-phenyl-propyl-(2')]-1, 1-diphenyl-propyl-(3)-amine (Segontin).
    MALTEZ JS
    J Med (Oporto); 1963 Jan; 50():189-202. PubMed ID: 13932641
    [No Abstract]   [Full Text] [Related]  

  • 12. [URINARY EXCRETION OF ADRENALINE AND NORADRENALINE IN CARDIAC INSUFFICIENCY. EFFECTS OF CARDIOKINETIC AND DIURETIC THERAPY ON BASIC CATECHOLAMINURIA].
    PILIEGO N; ROSSINI P
    Folia Cardiol; 1964; 23():271-82. PubMed ID: 14165891
    [No Abstract]   [Full Text] [Related]  

  • 13. [INVESTIGATION ON THE BEHAVIOR OF 3,3-DIPHENYL-N-(ALPHA-METHYLPHENETHYL)-3-PROPYLAMINE (SEGONTIN) AGAINST THE ACTION OF NORADRENALINE].
    LINDNER E
    Arch Int Pharmacodyn Ther; 1963 Dec; 146():475-84. PubMed ID: 14103284
    [No Abstract]   [Full Text] [Related]  

  • 14. Effects of some coronary "vasodilators" on myocardial catecholamine.
    Aoyama S
    Jpn Heart J; 1965 Jul; 6(4):335-45. PubMed ID: 4953370
    [No Abstract]   [Full Text] [Related]  

  • 15. [Blood monoamine oxidase activity and catecholamine excretion in young persons with coronary insufficiency].
    Aronov DM; Kiseleva ZM
    Kardiologiia; 1971 Aug; 11(8):34-8. PubMed ID: 5160873
    [No Abstract]   [Full Text] [Related]  

  • 16. [Clinical and electrocardiographic considerations on the use of a new synthesis (phenyl-propyl-diphenyl-propyl-amine) in the therapy of syndromes of coronary insufficiency in urologic patients].
    DE IASI A
    Minerva Med; 1963 Apr; 54():1212-7. PubMed ID: 14025812
    [No Abstract]   [Full Text] [Related]  

  • 17. [On the excretion of catecholamines in the urine during coronary arteriosclerosis].
    Toloknova EA
    Kardiologiia; 1967 Oct; 7(10):28-32. PubMed ID: 5607196
    [No Abstract]   [Full Text] [Related]  

  • 18. [CLINICAL STUDIES ON THE TREATMENT OF CORONARY INSUFFICIENCY WITH SEGONTIN].
    FRITZ E
    Med Klin; 1964 Aug; 59():1384-7. PubMed ID: 14253657
    [No Abstract]   [Full Text] [Related]  

  • 19. [3,3-diphenyl-N-(alpha-methylphenethyl)-propylamine.] (Segontin) in syndromes of coronary insufficiency. Preliminary note].
    DELLA PORTA P; LUCCHINI CR
    Minerva Cardioangiol; 1961 Sep; 9():533-6. PubMed ID: 13885183
    [No Abstract]   [Full Text] [Related]  

  • 20. [Excretion of free and bound catecholamines in the urine in ischemic heart disease].
    Orbetsova V; Orbetsov M; Beloev I; Dakovska L; Mikhaĭlova M
    Vutr Boles; 1978; 17(5):63-72. PubMed ID: 716373
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.